Gastroenterology

An expert discusses a study assessing the effects of low compliance to eosinophilic esophagitis therapies among pediatric patients.

Ustekinumab resulted in a reduction of both stool frequency and rectal bleeding for ulcerative colitis patients.

New research shows patients with chronic liver disease admitted for influenza had an increased risk of disease severity but not a higher odds of mortality.

More than half of the patient population achieved a defined response at both day 14 and week 6.

Research shows dupilumab remains effective in EoE for up to 2 years.

A new study presented at ACG shows vedolizumab to be superior to adalimumab in maintaining early disease control in patients with moderate-to-severe ulcerative colitis.

In data presented at ACG, investigators found a link between sex, lower BMI, and the development of irritable bowel syndrome in patients following a c. diff infection.

In a poster presented during ACG, investigators show data from a long-term extension of the UNIFI trial.

Patients with chronic pancreatitis can exhibit dependence on chronic opioid therapy prior to receiving total pancreatectomy with islet autotransplantation.

Isolation as a result of suspected C. Diff can take a significant financial toll on the healthcare system, thus it is necessary to determine appropriate factors that can predict CDI.

Investigators compared 2 groups, before and after the initiation of a biosimilar program at their hospital.

Relapses occurred in only 4 of 14 patients treated with the combination of Metronidazole with Vancomycin.

These findings suggest a potential in developing preventative vaccines against C. difficile infection.

In data presented at UEG, investigators find post-dupilumab transcriptome closely resembles the transcriptome of a healthy control group.

New data shows that clinical isolates of C. difficile are variably affected by manuka honey in terms of growth inhibition and bactericidal activity.

Only 29.5% of sampled CBD users claimed any wellness benefit.

The longitudinal study included 209 children, one of the largest samples in the world for a study on this topic.

The absolute SCr criterion correlated better with all-cause mortality than the relative increase in serum creatinine.

The study observed 50 women taking infliximab, adalimumab, and vedolizumab.

New cohort analysis shows patients with ulcerative colitis or Crohn's disease who have received invasive care may be affected long-term.

NASH and NAFLD are notoriously difficult to treat conditions.

TLR9 activation shows potential as a target for ulcerative colitis and warrants further testing.

These findings underline the importance of aggressive management to treat IBD and ACS comorbidities to improve outcomes.

Dr. Moon says new strategies must be implemented to help NAFLD patients deal with pain.

This edition from the 10 Year Plan features perspective from leadership at WGO and Crohn's & Colitis Foundation, as well as survey results from gastroenterologists.